Dimanche, 19 Novembre 2017
Dernières nouvelles
Principale » Penserra Capital Management LLC Buys 2178 Shares of Henry Schein, Inc. (HSIC)

Penserra Capital Management LLC Buys 2178 Shares of Henry Schein, Inc. (HSIC)

15 Novembre 2017

Moving 0.66% from the most recent open, shares of Henry Schein, Inc. In the case of HSIC, the chart has some interesting things to say about where the stock might be headed. The stock dropping with falling stream of -20.81% in recent 3 months.

A number of other institutional investors and hedge funds have also bought and sold shares of HSIC. Over the past week, shares are -5.87%. A month ago, analyst EPS consensus estimated earnings of US$0.99 per share.

Traders are a little more bearish on Henry Schein Inc recently if you take note of the uptick in short interest. Sun Life Financial INC now owns 580 shares of the company's stock worth $106,000 after purchasing an additional 573 shares during the last quarter. The stock has shown quarterly performance of 5.8% and a half-year performance stands at -1.02%. FTB Advisors Inc. increased its position in Henry Schein by 100.0% in the 3rd quarter.

Razer shares rise 41% on Hong Kong market debut
As reported by CNBC , the company went public earlier today and offered up around 1.06 billion primary shares. It released its first smartphone on November 1.

Based on the lastest quarterly filings, institutions continue to be large stakeholders in Henry Schein, Inc. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/11/14/jennison-associates-llc-buys-65945-shares-of-henry-schein-inc-hsic.html. The company's stock had a trading volume of 676,308 shares. During the same period in the prior year, the company posted $0.84 EPS. sell-side analysts anticipate that Henry Schein will post 3.6 earnings per share for the current year. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. Henry Schein, Inc. has a 52 week low of $67.44 and a 52 week high of $93.50. The value of the investment in (HSIC) went from $26,261,000 to $23,915,000 a change of 8.9% since the last quarter. The Higher end of the revenue forecast is $3.34 Billion, while the Lower end of the forecast is $3.06 Billion. Henry Schein, Inc. has a total market cap of $10898.93, a gross margin of 27.40% while the profit margin is 4.50% and the ROI is 13.80%. The business's revenue for the quarter was up 10.3% on a year-over-year basis. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.10, which implies that analysts are generally neutral in their outlook for HSIC over the next year. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. Future earnings predictions are perhaps the most essential input when trying to value a company. Janus Capital Management LLC now owns 2,027,848 shares of the company's stock valued at $358,522,000 after buying an additional 286,929 shares during the last quarter. Analysts have a mean recommendation of 2.10 on this stock. The total value of its holdings decreased 5.3%. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares of the company's stock, valued at approximately $3,077,750.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Stifel Nicolaus lowered the price target on November 7 cutting the projection from $89.00 to $77.00 and issued a "Hold" recommendation. Royal Bank Of Canada lowered their price target on Henry Schein from $91.00 to $82.00 and set a "sector perform" rating on the stock in a report on Tuesday. Jefferies Group LLC reissued a "hold" rating and set a $89.00 price target on shares of Henry Schein in a report on Friday, October 20th. Finally, Morgan Stanley began coverage on Henry Schein in a report on Thursday, September 21st. They set an "equal weight" rating and a $88.00 target price on the stock. TheStreet cut shares of Henry Schein from a b rating to a c+ rating in a research note on Monday, November 6th.

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services.